Company intelligence / Profile preview

BioFisherDX

Not explicitly stated; presumed international distribution.

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

BioFisherDX provides high-quality products in the field of molecular laboratory diagnostics with a focus on PCR, qPCR, and NGS technologies. The company distributes products from major producers globally to support clinical laboratories and improve patient outcomes.

Therapeutic areas: Other
Modalities: Device (diagnostic instruments)PCR-based diagnostics (Polymerase Chain Reaction)qPCR-based diagnostics (Quantitative Polymerase Chain Reaction)NGS-based diagnostics (Next Generation Sequencing)
Industry: Molecular Diagnostics

Partnerships

Not specified; distributes products from "the largest producers worldwide"

Beyond the preview

Go deeper on BioFisherDX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioFisherDX.

Explore the full profile